Intravenous Transplantation of Human Umbilical Cord Blood Mononuclear Cells Overexpressing Nerve Growth Factor Improves Spatial Memory in APP/PS1 Transgenic Mice with a Model of Alzheimer’s Disease
暂无分享,去创建一个
E. Petukhova | M. Mukhamedyarov | R. Islamov | A. V. Leushina | A. E. Tikhonova | R. Ben Taleb | M. Kaligin | A. L. Zefirov | A. Rizvanov | Y. Mukhamedshina | E. Garanina
[1] A. Palotás,et al. Tandem Delivery of Multiple Therapeutic Genes Using Umbilical Cord Blood Cells Improves Symptomatic Outcomes in ALS , 2017, Molecular Neurobiology.
[2] Eric Westman,et al. Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease , 2015, Alzheimer's & Dementia.
[3] A. Palotás,et al. Symptomatic improvement, increased life-span and sustained cell homing in amyotrophic lateral sclerosis after transplantation of human umbilical cord blood cells genetically modified with adeno-viral vectors expressing a neuro-protective factor and a neural cell adhesion molecule. , 2015, Current gene therapy.
[4] R. Pallini,et al. Human Olfactory Bulb Neural Stem Cells expressing hNGF Restore Cognitive Deficit in Alzheimer's Disease Rat Model , 2015, Journal of cellular physiology.
[5] A. Cuello,et al. Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome. , 2014, Trends in pharmacological sciences.
[6] H. Bobby Gaspar,et al. Hematopoietic SCT in Europe: data and trends in 2011 , 2013, Bone Marrow Transplantation.
[7] V. V. Solovieva,et al. Analysis of the Efficiency of Gene-Cell Therapy in Transgenic Mice with Amyotrophic Lateral Sclerosis Phenotype , 2013, Bulletin of Experimental Biology and Medicine.
[8] A. Zefirov,et al. [The influence of beta-amyloid peptide on the functions of excitable tissues: physiological and pathological aspects]. , 2013, Uspekhi fiziologicheskikh nauk.
[9] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.
[10] A. Cattaneo,et al. Transgenic Mice with Chronic NGF Deprivation and Alzheimer's Disease-Like Pathology Display Hippocampal Region-Specific Impairments in Short- and Long-Term Plasticities , 2010, The Journal of Neuroscience.
[11] Min Zhang,et al. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions , 2010, Journal of Translational Medicine.
[12] T. Sejnowski,et al. NGF Is Essential for Hippocampal Plasticity and Learning , 2009, The Journal of Neuroscience.
[13] S. Capsoni,et al. Development of a non invasive NGF-based therapy for Alzheimer's disease. , 2009, Current Alzheimer research.
[14] M. Tuszynski,et al. Therapeutic potential of CERE-110 (AAV2-NGF): Targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons , 2008, Experimental Neurology.
[15] D. Harris,et al. Umbilical cord blood: a unique source of pluripotent stem cells for regenerative medicine. , 2007, Current stem cell research & therapy.
[16] R. Dermietzel,et al. Proliferation, differentiation, and cytokine secretion of human umbilical cord blood-derived mononuclear cells in vitro. , 2007, Experimental hematology.
[17] M. Tuszynski,et al. Nerve Growth Factor Gene Therapy in Alzheimer Disease , 2007, Alzheimer disease and associated disorders.
[18] B. Melchior,et al. CNS immune privilege: hiding in plain sight , 2006, Immunological reviews.
[19] Sophie Pezet,et al. Neurotrophins: mediators and modulators of pain. , 2006, Annual review of neuroscience.
[20] J. Rawlins,et al. T-maze alternation in the rodent , 2006, Nature Protocols.
[21] A. Cattaneo,et al. Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice. , 2006, Journal of Alzheimer's disease : JAD.
[22] Z. Han,et al. Human umbilical cord blood cells express neurotrophic factors , 2005, Neuroscience Letters.
[23] Steven G Potkin,et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease , 2005, Nature Medicine.
[24] E. Ekestern. Neurotrophic Factors and Amyotrophic Lateral Sclerosis , 2004, Neurodegenerative Diseases.
[25] D. Swaab,et al. Alzheimer’s disease and NGF signaling , 2004, Journal of Neural Transmission.
[26] T. Hawley,et al. Multiparameter flow cytometry of fluorescent protein reporters. , 2004, Methods in molecular biology.
[27] P. Sanberg,et al. Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. , 2003, Journal of hematotherapy & stem cell research.
[28] A. Cattaneo,et al. β-Amyloid Plaques in a Model for Sporadic Alzheimer's Disease Based on Transgenic Anti-Nerve Growth Factor Antibodies , 2002, Molecular and Cellular Neuroscience.
[29] E. Huang,et al. Neurotrophins: roles in neuronal development and function. , 2001, Annual review of neuroscience.
[30] E. Alleva,et al. NGF expression in the developing rat brain: effects of maternal separation. , 2000, Brain research. Developmental brain research.
[31] W. Galpern,et al. NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease. , 1996, Neuroreport.
[32] W. Mcbride,et al. Performance in the cross‐maze and slip funnel tests of four pairs of rat lines selectively bred for divergent alcohol drinking behavior , 1996, Addiction biology.
[33] R. Macias,et al. NGF in experimental models of parkinson disease , 1996, Molecular and chemical neuropathology.
[34] E. Shooter,et al. Nerve growth factor in neuronal development and maintenance. , 1987, The Journal of experimental biology.
[35] F. Gage,et al. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[36] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.